| Literature DB >> 28235196 |
Laura Israel1, Ying Wang2, Katarzyna Bulek3, Erika Della Mina1, Zhao Zhang2, Vincent Pedergnana1, Maya Chrabieh1, Nicole A Lemmens4, Vanessa Sancho-Shimizu5, Marc Descatoire6, Théo Lasseau1, Elisabeth Israelsson7, Lazaro Lorenzo1, Ling Yun1, Aziz Belkadi1, Andrew Moran8, Leonard E Weisman9, François Vandenesch10, Frederic Batteux11, Sandra Weller6, Michael Levin12, Jethro Herberg12, Avinash Abhyankar13, Carolina Prando13, Yuval Itan13, Willem J B van Wamel4, Capucine Picard14, Laurent Abel15, Damien Chaussabel7, Xiaoxia Li3, Bruce Beutler2, Peter D Arkwright16, Jean-Laurent Casanova17, Anne Puel18.
Abstract
The molecular basis of the incomplete penetrance of monogenic disorders is unclear. We describe here eight related individuals with autosomal recessive TIRAP deficiency. Life-threatening staphylococcal disease occurred during childhood in the proband, but not in the other seven homozygotes. Responses to all Toll-like receptor 1/2 (TLR1/2), TLR2/6, and TLR4 agonists were impaired in the fibroblasts and leukocytes of all TIRAP-deficient individuals. However, the whole-blood response to the TLR2/6 agonist staphylococcal lipoteichoic acid (LTA) was abolished only in the index case individual, the only family member lacking LTA-specific antibodies (Abs). This defective response was reversed in the patient, but not in interleukin-1 receptor-associated kinase 4 (IRAK-4)-deficient individuals, by anti-LTA monoclonal antibody (mAb). Anti-LTA mAb also rescued the macrophage response in mice lacking TIRAP, but not TLR2 or MyD88. Thus, acquired anti-LTA Abs rescue TLR2-dependent immunity to staphylococcal LTA in individuals with inherited TIRAP deficiency, accounting for incomplete penetrance. Combined TIRAP and anti-LTA Ab deficiencies underlie staphylococcal disease in this patient.Entities:
Keywords: LTA; TIRAP; anti-LTA antibodies; incomplete clinical penetrance; lipoteichoic acid; primary immunodeficiency; staphylococcus aureus; toll-like receptors
Mesh:
Substances:
Year: 2017 PMID: 28235196 PMCID: PMC5328639 DOI: 10.1016/j.cell.2017.01.039
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 66.850